(Q41699374)

7 October 2017

1 reference

title

The status of hepatitis C virus screening (English)

1 reference

7 October 2017

1 reference

Allain JP

1

1 reference

7 October 2017

publication date

1 January 1998

1 reference

Transfusion Medicine Reviews

7 October 2017

published in

1 reference

7 October 2017

volume

12

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

46-55

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hepatitis C virus antibodies among risk groups in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Antibody to hepatitis C virus in German blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Infectivity of blood seropositive for hepatitis C virus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Antibody to superoxide dismutase, autoimmune hepatitis, and antibody tests for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

False-positive anti-HCV tests in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Washing with 8 mol/l urea to correct false-positive anti-HCV results

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Non-specificity of anti-HCV test for seroepidemiological analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Recombinant immunoblot assay for hepatitis C antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Early US experience with anti-HCV kit in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Marked improvement in sensitivity of second-generation tests for acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Early antihepatitis C virus response with second-generation C200/C22 ELISA

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Evidence for persistent hepatitis C virus (HCV) infection in hemophiliacs

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

All Exposed Hemophiliacs Have Markers of HCV

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hepatitis C virus in blood samples from volunteer donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hepatitis C virus among blood donors: follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Evaluation of laboratory assays for screening antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Non-A, Non-B Hepatitis and the Anti-HCV Assay

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Testing of blood donations for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Significance of NS3 and NS5 antigens in screening for HCV antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Recombinant immunoblot assay first and second generations on 732 blood donors reactive for antibodies to hepatitis C virus by ELISA. The Hepatitis Study Group of the French Society of Blood Transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Comparison of two anti‐hepatitis C virus enzyme‐linked immunosorbent assays

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Evaluation of third-generation screening and confirmatory assays for HCV antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Sensitivity of an anti‐HCV core peptide ELISA

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Peptide based enzyme immunoassays for detecting hepatitis C antibodies in sera of people at high risk

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hepatitis C virus antibodies and virus replication in asymptomatic blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Persistence of HCV despite antibodies to both putative envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

HCV core IgM and IgG antibodies in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Comparative evaluation of supplemental hepatitis C virus antibody test systems

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Clinical importance of HCV confirmatory testing in blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Evaluation of indeterminate c22-3 reactivity in volunteer blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

HCV confirmatory testing of blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

HCV confirmatory testing of blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Serological responses to infection with three different types of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Serological studies and hepatitis C virus RNA in serum samples from blood donors with indeterminate results in second-generation recombinant immunoblot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Significance of HCV RIBA-2 indeterminate results in high-risk individuals: assessment by a new third-generation RIBA assay and PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Confirmation of hepatitis C infection: a comparison of five immunoblot assays

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Failure of 2nd- and 3rd-generation HCV ELISA and RIBA to detect HCV polymerase chain reaction-positive donations

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Incorrect diagnosis of hepatitis C with RIBA-3

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Can the recombinant immunoblot assay generate an erroneous diagnosis of hepatitis C virus infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hepatitis C virus seroconversion rate in established blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Unexplained hepatitis C virus antibody seroconversion in established blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Supplemental HCV antibody assay in blood donors by RIBA and line immunoassay*

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Safety and efficacy of hepatitis C virus antibody screening of blood donors with two sequential screening assays

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Immunity in hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Sensitivity of serological assays to identify blood donors with hepatitis C viraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Look-back study of infectivity of anti-HCV ELISA-positive blood components

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Detection of serum hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Enhanced detection by PCR of hepatitis C virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hepatitis C virus RNA in symptomless donors implicated in post-transfusion non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hepatitis C viraemia in United Kingdom blood donors. A multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Determination of hepatitis C virus RNA in the serum by the Amplicor HCV PCR kit.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Quantitation of hepatitis C virus genome molecules in plasma samples

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Serum hepatitis C virus (HCV) RNA: a reliable tool for evaluating HCV-related liver disease in anti-HCV-positive blood donors with persistently normal alanine aminotransferase values

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Improvement of hepatitis C virus RNA polymerase chain reaction through a multicentre quality control study. French Study Group for the Standardization of Hepatitis C Virus PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

International collaborative study on the second EUROHEP HCV-RNA reference panel

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Long-term persistence of hepatitis C virus antibodies in a single source outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Chronic hepatitis C after high-dose intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Hepatitis C transmission associated with intravenous immunoglobulins.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Detection and characterization of hepatitis C virus RNA in immune globulins

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Detection and quantitation of hepatitis C virus RNA in serum using the polymerase chain reaction and a colorimetric enzymatic detection system

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

Rapid detection of hepatitis C virus RNA by direct capture from blood

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

High throughput PCR detection of HCV based on semiautomated multisample RNA capture

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2898%2980089-8

7 January 2021

10.1016/S0887-7963(98)80089-8

Identifiers

DOI

1 reference

7 October 2017

1 reference